1. Hou, Jianbing, Xu, Minghao, Gu, Hongyu, Chang, Hongbo, Cui, Hongjuan. 2022. ZC3H15 promotes glioblastoma progression through regulating EGFR stability. In Cell death & disease, 13, 55. doi:10.1038/s41419-021-04496-9. https://pubmed.ncbi.nlm.nih.gov/35027542/
2. Wang, Qing, Yue, Chao, Liu, Qin, Che, Xuchun. 2022. Exploration of differentially expressed mRNAs and miRNAs for pediatric acute myeloid leukemia. In Frontiers in genetics, 13, 865111. doi:10.3389/fgene.2022.865111. https://pubmed.ncbi.nlm.nih.gov/36160019/
3. Capalbo, Gianni, Mueller-Kuller, Thea, Koschmieder, Steffen, Hoelzer, Dieter, Scheuring, Urban J. 2013. Characterization of ZC3H15 as a potential TRAF-2-interacting protein implicated in the NFκB pathway and overexpressed in AML. In International journal of oncology, 43, 246-54. doi:10.3892/ijo.2013.1924. https://pubmed.ncbi.nlm.nih.gov/23624947/
4. Li, Qian, Hou, Jianbing, Guo, Chengda, Liu, Yaling, Cui, Hongjuan. 2021. ZC3H15 Correlates with a Poor Prognosis and Tumor Progression in Melanoma. In BioMed research international, 2021, 8305299. doi:10.1155/2021/8305299. https://pubmed.ncbi.nlm.nih.gov/34988227/
5. Jiang, Bei-Ge, Wan, Zheng-Hua, Huang, Jian, Pan, Ze-Ya, Zhou, Wei-Ping. . Elevated ZC3H15 increases HCC growth and predicts poor survival after surgical resection. In Oncotarget, 7, 37238-37249. doi:10.18632/oncotarget.9361. https://pubmed.ncbi.nlm.nih.gov/27191988/
智鼠故事 
